Effect ofNocardia rubra cell-wall skeleton on cancer prevention in humans

Summary The retired workers at the chemical weapons plant in Japan are regarded as a high-risk group for cancers. Under the Cancer Preventive Program,Nocardia rubra cell-wall skeleton (N-CWS) was administered to 80 workers directly involved in the production of sulfur mustard and 66 workers engaged in work related to sulfur mustard production. Untreated workers whose age, sex, duties and duration of work at this factory were individually matched to the N-CWS-treated workers were used as controls. During a 4.5-year observation period, development of cancers was found in 7 treated workers and 17 untreated controls. After elimination of the influence of the difference in smoking level, the incidence of subjects who developed cancers was compared statistically between the N-CWS-treated workers and the untreated controls and a significant suppression of development of cancers was noted in the N-CWS-treated workers. Thus, it was concluded that the administration of N-CWS could prevent cancer development in humans.     

The pairing of nucleolar patterns in an epithelium as evidence for a conserved nuclear skeleton

The nucleoli in epidermal cells of fifth instar Calpodes and Manduca larvae undergo three cycles of unravelling into necklaces with condensation back to a dense particle or particles. Mitosis occurs before the first cycle and at the beginning of the third cycle. In spite of the formation and condensation of these nucleolar necklaces the nucleoli in the intercycle condition all have paired patterns. Adjacent pairs of nuclei have nucleoli that resemble one another in the number of their component particles, the shape and size of the particles and sometimes in their arrangement as mirror images. The paired patterns begin at mitosis and reform after necklace elongation and condensation. The patterns are presumed to reflect a nuclear skeleton that is paired from mitosis and conserved until the next mitosis. The nuclear pairing is related to the retention of mid bodies by sibling cells so that the epidermis is a collection of minimal two-cell syncytia.     

A new trick for an old dog: The application of mifepristone in the treatment of adenomyosis

Adenomyosis is also called internal endometriosis and affects about 20% of reproductive‐aged women. It seriously reduces life quality of patients because current drug therapies face with numerous challenges. Long‐term clinical application of mifepristone exhibits wonderful therapeutic effects with mild side‐effects in many disorders since 1982. Since adenomyosis is a refractory disease, we investigate whether mifepristone can be applied in the treatment of adenomyosis. In this study, we investigated the direct effects of mifepristone on human primary eutopic endometrial epithelial cells and stromal cells in adenomyosis. We found that mifepristone causes cell cycle arrest through inhibiting CDK1 and CDK2 expressions and induces cell apoptosis via the mitochondria‐dependent signalling pathway in endometrial epithelial cells and stromal cells of adenomyosis. Furthermore, mifepristone inhibits the migration of endometrial epithelial cells and stromal cells through decreasing CXCR4 expression and restricts the invasion of endometrial epithelial cells via suppression of epithelial‐mesenchymal transition in adenomyosis. We also found that mifepristone treatment decreases the uterine volume, CA125 concentration and increases the haemoglobin concentration in serum for adenomyosis patients. Therefore, we demonstrate that mifepristone could serve as a novel therapeutic drug in the treatment of adenomyosis, and therefore, the old dog can do a new trick.